BANK VONTOBEL/CALL/ROCHE GS/320/0.02/20.12.24 Share Price

Warrant

WROBOV

CH1225163018

Market Closed - Swiss Exchange 08:50:00 16/05/2024 pm IST
0.014 CHF +40.00% Intraday chart for BANK VONTOBEL/CALL/ROCHE GS/320/0.02/20.12.24
3 months-50.00%
6 months-61.11%
Date Price Change
16/24/16 0.014 +40.00%

Delayed Quote Swiss Exchange

Last update May 16, 2024 at 08:50 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROBOV
ISINCH1225163018
Date issued 22/11/2022
Strike 320 CHF
Maturity 20/12/2024 (214 Days)
Parity 50 : 1
Emission price 0.48 CHF
Emission volume N/A
Settlement physical
Currency CHF

Technical Indicators

Highest since issue 0.53 CHF
Lowest since issue 0.008 CHF
Spread 0.01 CHF
Spread %41.67%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
237.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+17.84%
Consensus
  1. Stock Market
  2. Warrants
  3. WROBOV Warrant
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW